Bank of America
FSTX

Bank of America’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Bank of America’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-162
Closed -$1K – 8672
2022
Q1 		$1K Buy
+162
New +$598 ﹤0.01% 8171
2021
Q4 		– Sell
-264
Closed -$2K – 8878
2021
Q3 		$2K Buy
264
+257
+3,671% +$1.76K ﹤0.01% 7935
2021
Q2 		$0 Buy
+7
New +$60 ﹤0.01% 8267
2019
Q4 		– Sell
-166
Closed -$2K – 7539
2019
Q3 		$2K Sell
166
-2,405
-94% -$39.6K ﹤0.01% 7029
2019
Q2 		$38K Buy
2,571
+1,885
+275% +$50.5K ﹤0.01% 6405
2019
Q1 		$29K Sell
686
-1,201
-64% -$50.6K ﹤0.01% 6394
2018
Q4 		$79K Buy
1,887
+1,184
+168% +$53.2K ﹤0.01% 6033
2018
Q3 		$34K Buy
703
+217
+45% +$10.9K ﹤0.01% 6362
2018
Q2 		$23K Buy
486
+3
+0.6% +$166 ﹤0.01% 6474
2018
Q1 		$30K Buy
+483
New +$25.5K ﹤0.01% 6242
2016
Q4 		– Sell
-88
Closed -$4K – 7426
2016
Q3 		$4K Buy
88
+38
+76% +$1.64K ﹤0.01% 6696
2016
Q2 		$2K Buy
+50
New +$2.14K ﹤0.01% 6926

Other funds holding FSTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America's FSTX Position: Q2 2022 in Review

Bank of America sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2022, closing a stake of 162 shares — an estimated $1K sold.

Bank of America first reported a position in FSTX in Q2 2016 and held it in 12 quarters. The position peaked at $79K in Q4 2018. 53 funds tracked by Wall St. Rank hold FSTX as of Q2 2022.

  • Bank of America reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Bank of America sold 162 F-star Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $1K.
  • Bank of America first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2016 and held it in 12 quarters.
  • Bank of America's F-star Therapeutics, Inc. Common Stock position peaked at $79K in Q4 2018.
  • 53 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Bank of America's 13F filing for Q2 2022, filed 12 Aug 2022.